We are live on ! Find out more
KANG

iKang Healthcare Group, Inc.
KANG

Delisted

KANG was delisted on the 18th of January, 2019.

71 hedge funds and large institutions have $522M invested in iKang Healthcare Group, Inc. in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 11

42% more funds holding

Funds holding: 5071 (+21)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

17% more capital invested

Capital invested by funds: $445M → $522M (+$77M)

12% less call options, than puts

Call options by funds: $1.68M | Put options by funds: $1.91M

21% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 19

Holders
71
Holders Change
+21
Holders Change %
+42%
% of All Funds
1.91%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
33
Increased
15
Reduced
19
Closed
11
Calls
$1.68M
Puts
$1.91M
Net Calls
-$229K
Net Calls Change
-$3.62M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$151M -$72.9M -3,966,774 -34%
JC
2
Joho Capital
New York
$54.6M +$51.9M +2,822,655 New
JP Morgan Chase
3
JP Morgan Chase
New York
$41.1M -$33.4M -1,819,340 -46%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$40.1M +$1.91M +104,000 +5%
FI
5
Fosun International
China
$33M +$31.3M +1,704,827 New
MAM
6
Myriad Asset Management
Hong Kong
$19.8M
VAM
7
Visium Asset Management
New York
$17M -$12M -654,269 -43%
Fidelity International
8
Fidelity International
Bermuda
$13.8M +$2.89M +157,500 +28%
NCMC
9
NewQuest Capital Management (Cayman)
Cayman Islands
$13.6M -$11.9M -646,027 -48%
PRCM
10
Pine River Capital Management
Minnesota
$13.5M +$9M +489,638 +233%
BG
11
BlackRock Group
United Kingdom
$13.4M +$12.7M +690,321 New
OCAM
12
Owl Creek Asset Management
New York
$12M +$1.89M +103,055 +20%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$9.22M +$8.76M +476,800 New
LA
14
LBN Advisers
Hong Kong
$8.4M +$3.09M +168,100 +63%
JGC
15
J. Goldman & Co
New York
$7.43M -$1.21M -65,947 -15%
BA
16
BlackRock Advisors
Delaware
$6.72M +$6.39M +347,577 New
CS
17
Candriam SCA
Luxembourg
$6.25M -$3.05M -166,000 -34%
OAM
18
Oberweis Asset Management
Illinois
$4.73M +$296K +16,100 +7%
JAM
19
Jupiter Asset Management
United Kingdom
$4.04M -$18.8K -1,025 -0.5%
CCAM
20
Coupland Cardiff Asset Management
United Kingdom
$3.87M +$3.68M +200,000 New
AG
21
Ashmore Group
United Kingdom
$3.86M -$4.26M -232,036 -54%
CI Investments Inc
22
CI Investments Inc
Ontario, Canada
$3.38M +$677K +36,850 +27%
GH
23
GAM Holding
Switzerland
$3.19M +$3.04M +165,508 New
CWG
24
C WorldWide Group
Denmark
$3.09M +$2.94M +160,000 New
HCMT
25
Highland Capital Management (Texas)
Texas
$2.9M

KANG Hedge Fund Activity: Q2 2015 in Review

71 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q2 2015, worth a combined $522M — up 17% from $445M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KANG positions and 11 closed out — a net gain of 22 holders — while 15 added to existing stakes and 19 trimmed.

The largest buyer was Joho Capital, opening a new position worth an estimated $51.9M. The largest seller was Goldman Sachs, cutting an estimated $72.9M.

  • 71 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q2 2015, up from 50 in Q1 2015.
  • Funds reported $522M of iKang Healthcare Group, Inc. stock for Q2 2015, up 17% quarter-over-quarter.
  • 33 funds opened new iKang Healthcare Group, Inc. positions in Q2 2015 and 11 closed out, a net change of +22 holders.
  • The largest iKang Healthcare Group, Inc. buyer in Q2 2015 was Joho Capital, an estimated $51.9M added.
  • The largest iKang Healthcare Group, Inc. seller in Q2 2015 was Goldman Sachs, an estimated $72.9M sold.

Based on aggregated 13F filings for Q2 2015.